265 related articles for article (PubMed ID: 31847491)
1. The mTOR Signaling Pathway Activity and Vitamin D Availability Control the Expression of Most Autism Predisposition Genes.
Trifonova EA; Klimenko AI; Mustafin ZS; Lashin SA; Kochetov AV
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847491
[TBL] [Abstract][Full Text] [Related]
2. Do Autism Spectrum and Autoimmune Disorders Share Predisposition Gene Signature Due to mTOR Signaling Pathway Controlling Expression?
Trifonova EA; Klimenko AI; Mustafin ZS; Lashin SA; Kochetov AV
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065644
[TBL] [Abstract][Full Text] [Related]
3. [Abnormal mTOR Signaling Pathway Activity in Autism Spectrum Disorders: Prospects of Mechanism-Based Therapy].
Trifonova EA; Kotliarova AA; Kochetov AV
Mol Biol (Mosk); 2023; 57(2):243-253. PubMed ID: 37000653
[TBL] [Abstract][Full Text] [Related]
4. Abnormal mTOR Activation in Autism.
Winden KD; Ebrahimi-Fakhari D; Sahin M
Annu Rev Neurosci; 2018 Jul; 41():1-23. PubMed ID: 29490194
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of mTOR signaling mediates common neurite and migration defects in both idiopathic and 16p11.2 deletion autism neural precursor cells.
Prem S; Dev B; Peng C; Mehta M; Alibutud R; Connacher RJ; St Thomas M; Zhou X; Matteson P; Xing J; Millonig JH; DiCicco-Bloom E
Elife; 2024 Mar; 13():. PubMed ID: 38525876
[TBL] [Abstract][Full Text] [Related]
6. mTOR, a Potential Target to Treat Autism Spectrum Disorder.
Sato A
CNS Neurol Disord Drug Targets; 2016; 15(5):533-43. PubMed ID: 27071790
[TBL] [Abstract][Full Text] [Related]
7. Abnormal mTOR Activity in Pediatric Autoimmune Neuropsychiatric and MIA-Associated Autism Spectrum Disorders.
Trifonova EA; Mustafin ZS; Lashin SA; Kochetov AV
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055151
[TBL] [Abstract][Full Text] [Related]
8. Effects of rapamycin on social interaction deficits and gene expression in mice exposed to valproic acid in utero.
Kotajima-Murakami H; Kobayashi T; Kashii H; Sato A; Hagino Y; Tanaka M; Nishito Y; Takamatsu Y; Uchino S; Ikeda K
Mol Brain; 2019 Jan; 12(1):3. PubMed ID: 30621732
[TBL] [Abstract][Full Text] [Related]
9. Autism spectrum disorder and brain volume link through a set of mTOR-related genes.
Arenella M; Mota NR; Teunissen MWA; Brunner HG; Bralten J
J Child Psychol Psychiatry; 2023 Jul; 64(7):1007-1014. PubMed ID: 36922714
[TBL] [Abstract][Full Text] [Related]
10. SFARI genes and where to find them; modelling Autism Spectrum Disorder specific gene expression dysregulation with RNA-seq data.
Arpi MNT; Simpson TI
Sci Rep; 2022 Jun; 12(1):10158. PubMed ID: 35710789
[TBL] [Abstract][Full Text] [Related]
11. Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?
Magdalon J; Sánchez-Sánchez SM; Griesi-Oliveira K; Sertié AL
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335463
[TBL] [Abstract][Full Text] [Related]
12. Pathway Network Analyses for Autism Reveal Multisystem Involvement, Major Overlaps with Other Diseases and Convergence upon MAPK and Calcium Signaling.
Wen Y; Alshikho MJ; Herbert MR
PLoS One; 2016; 11(4):e0153329. PubMed ID: 27055244
[TBL] [Abstract][Full Text] [Related]
13. The role of reduced expression of fragile X mental retardation protein in neurons and increased expression in astrocytes in idiopathic and syndromic autism (duplications 15q11.2-q13).
Wegiel J; Brown WT; La Fauci G; Adayev T; Kascsak R; Kascsak R; Flory M; Kaczmarski W; Kuchna I; Nowicki K; Martinez-Cerdeno V; Wisniewski T; Wegiel J
Autism Res; 2018 Oct; 11(10):1316-1331. PubMed ID: 30107092
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing and gene co-expression network-based analysis of dizygotic twins with autism-spectrum disorder and their parents.
Okay K; Varış PÜ; Miral S; Ekinci B; Yaraş T; Karakülah G; Oktay Y
Genomics; 2021 Jul; 113(4):2561-2571. PubMed ID: 34087420
[TBL] [Abstract][Full Text] [Related]
15. [Research advances in the role of mTOR signaling pathway in autism spectrum disorder].
Sheng GX; Jiang KW
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jul; 21(7):718-723. PubMed ID: 31315775
[TBL] [Abstract][Full Text] [Related]
16. Protein Phosphorylation Signaling Cascades in Autism: The Role of mTOR Pathway.
Boksha IS; Prokhorova TA; Tereshkina EB; Savushkina OK; Burbaeva GS
Biochemistry (Mosc); 2021 May; 86(5):577-596. PubMed ID: 33993859
[TBL] [Abstract][Full Text] [Related]
17. Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR.
Oguro-Ando A; Rosensweig C; Herman E; Nishimura Y; Werling D; Bill BR; Berg JM; Gao F; Coppola G; Abrahams BS; Geschwind DH
Mol Psychiatry; 2015 Sep; 20(9):1069-78. PubMed ID: 25311365
[TBL] [Abstract][Full Text] [Related]
18. Dietary interventions that reduce mTOR activity rescue autistic-like behavioral deficits in mice.
Wu J; de Theije CGM; da Silva SL; Abbring S; van der Horst H; Broersen LM; Willemsen L; Kas M; Garssen J; Kraneveld AD
Brain Behav Immun; 2017 Jan; 59():273-287. PubMed ID: 27640900
[TBL] [Abstract][Full Text] [Related]
19. mTOR signalling pathway - A root cause for idiopathic autism?
Ganesan H; Balasubramanian V; Iyer M; Venugopal A; Subramaniam MD; Cho SG; Vellingiri B
BMB Rep; 2019 Jul; 52(7):424-433. PubMed ID: 31186084
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the PI3K catalytic subunit p110δ underlies elevated S6 phosphorylation and protein synthesis in an individual with autism from a multiplex family.
Poopal AC; Schroeder LM; Horn PS; Bassell GJ; Gross C
Mol Autism; 2016; 7():3. PubMed ID: 26770665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
